Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: The emerging role of p27(kip) in malignant transformation of neurofibromas

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 1885-1891

  Kourea, Helen P ^a,b   Cordon Cardo, Carlos ^a   Dudas, Maria ^a   Leung, Denis ^a   Woodruff, James M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27;

ARTICLE; BENIGN TUMOR; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NERVE SHEATH TUMOR; NEUROFIBROMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0032762177     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65508-3     Document Type: Article

References (39)

1. Matsushime H, Ewen ME, Strom DK, Kato J, Hanks SK, Roussel MP, Sherr CI: Identification and properties of an atypical catalytic subunit (p34 PSK-J3/Cdk4) for mammalian D-type cyclins. Cell 1992, 71: 323-334
2. Meyerson M, Harlow E: Identification of G1 kinase activity for Cdk6, a novel cyclin D partner. Mol Cell Biol 1994, 14:2077-2086
3. Cordon-Cardo C: Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995, 147: 545-560
4. Lee W-H, Shew J-Y, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY: The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987, 329:642-645
5. Nevins JR: E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992, 258:424-429
6. Hirama T, Koeffler HP: Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995, 86:841-854
7. Sherr C: G1 phase progression: Cycling on cue. Cell 1994, 79: 551-555
8. Dowdy SF, Hinds PW, Loule K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993, 73:499-511
9. Geng Y, Ng Eaton E, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C, Weinberg RA: Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 1996, 12:1173-1180
10. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M: Human cyclin E, a nuclear protein essential for G1 to S phase transition. Mol Cell Biol 1995, 15:2612-2624
11. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 5:805-816
12. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: P21 a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704
13. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74
14. Lee M-H, Reynisdottir I, Massague J: Cloning of p57kip2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995, 9:639-649
15. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707
16. Hannon GJ, Beach D: P15INK4B is a potential effector of TGF-b induced cell cycle arrest. Nature 1994, 371:257-261
17. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y: Growth suppression by p18, a p16INK4/MTS1-and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild type pRb function. Genes Dev 1994, 8:2939-2952
18. Chan FKM, Zhang J, Cneng L, Shapiro DN, Winoto A: Identification of human and mouse p19, a novel CDK4and CDK6 inhibitor with homology to p16INK4. Mol Cell Biol 1995, 15:2682-2688
19. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumour suppression. Cell 1993, 75:817-825
20. Polyak K, Lee M-H, Erjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J: Cloning of p27kip, a cyclin-dependent kinase inhibitor amd potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66
21. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP, Barker DF, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR: Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 1990, 87:5435-5439
22. Legius E, Dierick H, Wu R, Hall BK, Marynen P, Cassiman JJ, Glover TW: TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosom Cancer 1994, 10:250-255
23. Kindblom LG, Ahlden M, Meis-Kindblom JM, Stenman G: Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant nerve sheath tumors. Virchows Arch 1995, 427:19-26
24. Halling KC, Scheithauer BW, Halling A, Nascimento AG, Ziesmer SC, Roche PC, Wollan PC: p53 expression in neurofibroma and malignant peripheral nerve sheath tumor: an immunohistochemical study of sporadic and NF1-associated tumors. Am J Clin Pathol 1996, 106: 282-288
25. Erlandson RA, Woodruff JM: Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer 1982, 49:273-287
26. Woodruff JM: Pathology of major peripheral nerve sheath tumors. Soft Tissue Tumors, International Academy of Pathology Monograph. Edited by SW Weiss and JSJ Brooks. Baltimore, Williams and Wilkins, 1996, pp 129-161
27. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM: Malignant peripheral nerve sheath tumor. A clinicopathologic study of 120 cases. Cancer 1986, 57:2006-2021
28. Hruban RH, Shiu MH, Senie RT, Woodruff JM: Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 1990, 66:1253-1265
29. Kourea HP, Bilsky MH, Leung DH, Lewis JJ, Woodruff JM: Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumor. A clinicopathologic study of 25 patients and 26 tumors. Cancer 1998, 82:2191-2203
30. Karpeh MS, Brennan MF, Cance WG, Woodruff JM, Pollack D, Casper ES, Dudas ME, Latres E, Drobnjak M, Cordon-Cardo C: Altered expression of retinoblastoma gene product in adult soft tissue sarcomas. Br J Cancer 1995, 72:986-991
31. 1. Cancer Res 1998, 58: 1090-1094
32. Stefanaki K, Tzardi M, Kouvidou C, Chaniotis V, Botioti M, Vlychou M, Zois M, Kakolyris S, Delides G, Rontogianni D, Georgoulias V, Kanavaros P: Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue. Anti-cancer Res 1998, 18:2403-2408
33. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994, 54:3391-3395
34. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 1995, 55:2266-2269
35. Ponce-Castaneda MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, Cordon-Cardo C: P27 Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995, 55: 1211-1214
36. Pagano M, Tam SW, Theodoras AN, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995, 269:682-685
37. Soucek T, Yeung RS, Hengstshlager M: Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci USA 1998, 95:15653-15658
38. Clurman BE, Porter P: New insights into the tumor suppressor function of p27KIP1. Proc Natl Acad Sci USA 1998, 95:15158-15160
39. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE: Cyclin E-CDK2 is a regulator of p27kip1. Genes Dev 1997, 11:1464-1478